Your browser doesn't support javascript.
loading
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions.
Raghav, Pawan Kumar; Mann, Zoya; Ahluwalia, Simran Kaur; Rajalingam, Raja.
Afiliação
  • Raghav PK; Immunogenetics and Transplantation Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA. Electronic address: PwnRghv@gmail.com.
  • Mann Z; BioExIn, Delhi, India.
  • Ahluwalia SK; Amity Institute of Biotechnology, Amity University, Sector-125, Noida, Uttar Pradesh, India.
  • Rajalingam R; Immunogenetics and Transplantation Laboratory, Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
J Pharmacol Sci ; 152(1): 1-21, 2023 May.
Article em En | MEDLINE | ID: mdl-37059487
ABSTRACT
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection is caused when Spike-protein (S-protein) present on the surface of SARS-CoV-2 interacts with human cell surface receptor, Angiotensin-converting enzyme 2 (ACE2). This binding facilitates SARS-CoV-2 genome entry into the human cells, which in turn causes infection. Since the beginning of the pandemic, many different therapies have been developed to combat COVID-19, including treatment and prevention. This review is focused on the currently adapted and certain other potential therapies for COVID-19 treatment, which include drug repurposing, vaccines and drug-free therapies. The efficacy of various treatment options is constantly being tested through clinical trials and in vivo studies before they are made medically available to the public.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: J Pharmacol Sci Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: J Pharmacol Sci Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article